The arthritis severity quantitative trait loci Cia4 and Cia6 regulate neutrophil migration into inflammatory sites and levels of TNF-alpha and nitric oxide.
Neutrophils are required for the development of arthritis, and their migration into the synovial tissue coincides with the onset of clinical disease. Synovial neutrophil numbers also correlate with rheumatoid arthritis disease activity and severity. We hypothesized that certain arthritis severity genes regulate disease via the regulation of neutrophil migration into the joint. This hypothesis was tested in the synovial-like air pouch model injected with carrageenan using arthritis-susceptible DA and arthritis-resistant F344 rats. DA had nearly 3-fold higher numbers of exudate neutrophils compared with F344 (p < 0.001). Five DA.F344(QTL) strains congenic for severity loci and protected from autoimmune arthritis were studied. Only DA.F344(Cia4) (chromosome 7) and DA.F344(Cia6) (chromosome 8) congenics had significantly lower exudate neutrophil counts compared with DA. TNF-alpha levels were 2.5-fold higher in DA exudates as compared with F344 exudates, and that difference was accounted for by the Cia4 locus. Exudate levels of NO, a known inhibitor of neutrophil chemotaxis, were higher in F344, compared with DA, and that difference was accounted for by Cia6. This is the first time that non-MHC autoimmune arthritis loci are found to regulate three central components of the innate immune response implicated in disease pathogenesis, namely neutrophil migration into an inflammatory site, as well as exudate levels of TNF-alpha and NO. These observations underscore the importance of identifying the Cia4 and Cia6 genes, and suggest that they should generate useful novel targets for development of new therapies.
Laragione
Teresina
T
Laboratory of Experimental Rheumatology, Robert S. Boas Center for Genomics and Human Genetics, The Feinstein Institute for Medical Research, Manhasset, NY, USA.
Yarlett
Nuriza C
NC
Brenner
Max
M
Mello
Adriana
A
Sherry
Barbara
B
Miller
Edmund J
EJ
Metz
Christine N
CN
Gulko
Pércio S
PS
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000235:genetics* / Q000276:immunology / Q000628:therapy; D002633:Chemotaxis / Q000235:genetics* / Q000276:immunology; D002875:Chromosomes / Q000235:genetics / Q000276:immunology; D007113:Immunity, Innate / Q000235:genetics; D009504:Neutrophils / Q000276:immunology*; D009569:Nitric Oxide / Q000235:genetics / Q000276:immunology*; D040641:Quantitative Trait Loci / Q000276:immunology; D051381:Rats; D011916:Rats, Inbred F344; D012720:Severity of Illness Index; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000276:immunology*
D014409:Tumor Necrosis Factor-alpha; D009569:Nitric Oxide